House of Commons · Written Ministerial Statement
Business update
20 July 2020 · Department for Business, Energy and Industrial Strategy
Proposed by Alok Sharma Con Reading West
Summarised by AI from the official record, so it can contain mistakes.
At a glance
Key points
- The Vaccine Taskforce has secured agreements with BioNTech/Pfizer and Valneva for vaccine procurement.
- A letter of intent for an antibody therapeutic from AstraZeneca has been announced.
- The NHS Covid-19 vaccine research registry has been launched to facilitate public participation in future vaccine studies.
Issue summary
The statement provides an update on the progress of the Vaccine Taskforce's efforts to secure a successful COVID-19 vaccine for the UK population and globally.
Action requested
The minister announces agreements with BioNTech/Pfizer and Valneva for vaccine procurement, and a letter of intent for an antibody therapeutic from AstraZeneca. The NHS Covid-19 vaccine research registry is launched to facilitate public participation in future vaccine studies.
Key facts
- We have signed agreements with the BioNTech/Pfizer alliance and Valneva.
- A letter of intent has been issued for an antibody therapeutic from AstraZeneca, potentially available by Q2 2021 if trials are successful.
- The NHS Covid-19 vaccine research registry is launched to enable public participation in future studies.